Citation: Yao Yangyang, Liu Xiaoyu, Yang Feilong, Yang Ying, Yuan Tianyi, Fang Lianhua, Du Guanhua, Jiao Xiaozhen, Xie Ping. Design, Synthesis and Biological Activity Evaluation of Novel Rho Kinase Inhibitors[J]. Chinese Journal of Organic Chemistry, ;2018, 38(4): 871-882. doi: 10.6023/cjoc201711007 shu

Design, Synthesis and Biological Activity Evaluation of Novel Rho Kinase Inhibitors

a.
State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050
b.
State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Beijing Key Laboratory of Drug Targets Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050

Corresponding author: Jiao Xiaozhen, jiaoxz@imm.ac.cn Xie Ping, xp@imm.ac.cn
Received Date: 3 November 2017
Revised Date: 24 November 2017
Available Online: 5 April 2017
Fund Project: Project supported by the Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences (No. CIFMS 2016-I2M-3-009) and the Fundamental Research Funds for Chinese Academy of Medical Sciences (CAMS)/Peking Union Medical College (PUMC) (No. 2016ZX350024)the Fundamental Research Funds for Chinese Academy of Medical Sciences (CAMS)/Peking Union Medical College (PUMC) 2016ZX350024Project supported by the Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences CIFMS 2016-I2M-3-009

Figures(5)

Based on the structure of N-(1H-indazol-5-yl)-1-(4-methylbenzyl) pyrrolidine-3-carboxamide (I), which was previously obtained via a structure-based optimization of ROCK 1 inhibitor, sixteen novel 1-substituted-(1H-indazol-5-yl)tetrahydro pyrimidin-2(1H)-one derivatives were designed and synthesized via an active substructure combination strategy. The structures of the target compounds were confirmed by ¹H NMR, ¹³C NMR and HRMS. The bioassay data indicated that 1-(1H-indazol-5-yl)-3-(4-nitrophenyl) tetrahydropyrimidin-2(1H)-one (8a) and 4-(3-(1H-indazol-5-yl)-2-oxo tetrahydropyrimidin-1(2H)-yl)benzonitrile (8b) had good activities against ROCK I. The IC₅₀ values for 8a and 8b were 6.01 and 9.46 μmol·L^-1, respectively. Moreover, ex vivo studies demonstrated that 8a and 8b exhibited vasorelaxant activity in rat basilar artery ring. The EC₅₀ values for 8a and 8b were 15.92 and 20.61 μmol·L^-1, respectively.
- Rho-associated kinase,
- cardio-cerebrovascular disease,
- tetrahydro pyrimidin-2(1H)-one derivative,
- inhibitor
1. [1]
  Zhang, X. F.; Hu, D. Y.; Ding, R. J.; Wang, H. C.; Yan, L. X. Chin. J. Cardiol. 2012, 40, 179.
2. [2]
  Matozaki, T.; Nakanishi, H.; Takai, Y. Cell. Signalling 2000, 12, 515. doi: 10.1016/S0898-6568(00)00102-9
3. [3]
  Mueller, B. K.; Mack, H.; Teuseh, N. Nat. Rev. Drug Discovery 2005, 4, 387. doi: 10.1038/nrd1719
4. [4]
  Riento, K.; Ridley, A. J. Nat. Rev. Mol. Cell Biol. 2003, 4, 446. doi: 10.1038/nrm1128
5. [5]
  Nakagawa, O.; Fujisawa, K.; Ishizaki, T.; Saito, Y.; Nakao, K.; Narumiya, S. FEBS Lett. 1996, 392, 189. doi: 10.1016/0014-5793(96)00811-3
6. [6]
  Wirth, A. Biochim. Biophys. Acta 2010, 1802, 1276. doi: 10.1016/j.bbadis.2010.05.002
7. [7]
  Barbara, E. R.; Nathalie, F. W.; Cameron, J. W.; Julie, H. C.; Gordon, R. C. Atherosclerosis 2005, 183, 1. doi: 10.1016/j.atherosclerosis.2005.04.023
8. [8]
  Surma, M.; Wei, L.; Shi, J. J. Future Cardiol. 2011, 7, 657. doi: 10.2217/fca.11.51
9. [9]
  Sauzeau, V.; Le, M. E.; Bertoqlio, J.; Scalbert, E.; Pacaud, P.; Loirand, G. Circ. Res. 2001, 88, 1102. doi: 10.1161/hh1101.092034
10. [10]
  Shin, H.; Salomone, S.; Ayata, C. Expert Opin. Ther. Targets 2008, 12, 1547. doi: 10.1517/14728220802539244
11. [11]
  Hu, E.; Lee, D. Curr. Opin. Invest. Drugs 2003, 4, 1065.
12. [12]
  Nakahara, T.; Moriuchi, H.; Yunoki, M.; Sakamato, K. Y Eur. J. Pharmacol. 2000, 389, 103. doi: 10.1016/S0014-2999(99)00891-2
13. [13]
  Oka, M.; Fagan, K.; Jone, P.; McMutry, I. Br. J. Pharmacol. 2008, 155, 444.
14. [14]
  Ying, H.; Biroc, S. L.; Li, W.; Alicke, B.; Xuan, J. A. Mol. Cancer Ther. 2005, 5, 2158.
15. [15]
  Somlyo, C.; Phelps, C.; Dipiperro, M.; Eto, M.; Read, P.; Barrett, M.; Gibson, J. FASEB J. 2003, 17, 223. doi: 10.1096/fj.02-0655com
16. [16]
  Feng, Y. B.; Cameron, M. D.; Frackowiak, B.; Evelyn, G.; Li L.; Claudia R.; Thomas, S.; Philip, L. Bioorg. Med. Chem. Lett. 2007, 17, 2355. doi: 10.1016/j.bmcl.2006.12.043
17. [17]
  Chen, Y. T.; Thomas, D. B.; Weiser, A.; Griffin, E.; Lin, L.; Ruiz, C.; Michael, D. C.; Stephan, S.; Derek, D.; Thomas, S.; LoGrasso, P.; Feng, Y. B. Bioorg. Med. Chem. Lett. 2008, 18, 6406. doi: 10.1016/j.bmcl.2008.10.080
18. [18]
  Sessions, E. H.; Yin, Y.; Thomas, D. B.; Weiser, A.; Griffin, E.; Pocas, J.; Cameron, M. D.; Ruiz, C.; Lin, L.; Schurer, S. C.; Schroter, T.; LoGrasso, P.; Feng, Y. B. Bioorg. Med. Chem. Lett. 2008, 18, 6390. doi: 10.1016/j.bmcl.2008.10.095
19. [19]
  Sessions, E. H.; Smolinski, M.; Wang, B.; Frackowiak, B.; Chowdhury, S.; Yin, Y.; Chen, Y. T.; Ruiz, C.; Lin, L.; Pocas, J.; Schroter, T.; Cameron, M. D.; LoGrasso, P.; Feng, Y. B.; Bannister, T. D. Bioorg. Med. Chem. Lett. 2010, 20, 1939. doi: 10.1016/j.bmcl.2010.01.124
20. [20]
  Yin, Y.; Lin, L.; Ruiz C.; Cameron, M. D.; Pocas, J.; Grant, W.; Schroter, T.; Chen, W.; Duckett, D.; Schurer, S.; LoGrasso, P.; Feng, Y. B. Bioorg. Med Chem. Lett. 2009, 19, 6686. doi: 10.1016/j.bmcl.2009.09.115
21. [21]
  Fang, X. G.; Chen, Y. T.; Sessions, E. H.; Chowdhury, S.; Vojkovsky, T.; Yin, Y.; Pocas, J. R.; Grant, W.; Schroter, T.; Lin, L.; Ruiz, C.; Cameron, M. D.; LoGrasso, P.; Feng, Y. B. Bioorg. Med. Chem. Lett. 2011, 21, 1844. doi: 10.1016/j.bmcl.2011.01.039
22. [22]
  Chowdhury, S.; Chen, Y. T.; Fang, X. G.; Grant, W.; Pocas, J.; Cameron, M. D.; Ruiz, C.; Lin, L.; Park, H.; Schroter, T.; Bannister, T. D.; Feng, Y. B. Bioorg. Med. Chem. Lett. 2013, 23, 1592. doi: 10.1016/j.bmcl.2013.01.109
23. [23]
  Takami, A.; Iijima, H.; Iwakubo, M.; Okada, Y. EP 1256574, 2001.
24. [24]
  Iwakubo, M.; Takami, A.; Okada, Y.; Kawata, T.; Tagami, Y.; Sato, M.; Sugiyama, T.; Fukushima, K.; Taya, S.; Amano, M.; Kaibuchi, K.; Iijima, H. Bioorg. Med. Chem. 2007, 15, 1022. doi: 10.1016/j.bmc.2006.10.028
25. [25]
  Henderson, A. J.; Hadden, M.; Guo, C.; Douglas, N.; Decornez, H.; Hellberg, M. R.; Rusinko, A.; McLaughlin, M.; Sharif, N.; Drace, C.; Patril, R. Bioorg. Med. Chem. Lett. 2010, 20, 1137. doi: 10.1016/j.bmcl.2009.12.012
26. [26]
  Feng, Y. B.; Philip, V. L.; Olivier, D.; Li, R. S. J. Med. Chem. 2016, 59, 2269. doi: 10.1021/acs.jmedchem.5b00683
27. [27]
  Yao, Y. Y.; Li, R. Z.; Liu, X. Y.; Yang, F. L.; Yang, Y.; Li, X. Y.; Shi, X.; Yuan, T. Y.; Fang, L. H.; Du, G. H.; Jiao, X. Z.; Xie, P. Molecules 2017, 22, 1766. doi: 10.3390/molecules22101766
28. [28]
  Li, R. S.; Martin, M. P.; Liu, Y.; Khan, S.; Cameron, M. D.; Grant, W.; Pocas, J.; Eid, N.; Park, H.; Schroter, T.; LoGrasso, P.; Feng, Y. B. J. Med. Chem. 2012, 55, 2474. doi: 10.1021/jm201289r
29. [29]
  Chen, J. Q.; Li, Q. Preparation and Synthesis of Modern Drugs, Chemical Industry Press, Beijing, 2011, p. 55(in Chinese).
30. [30]
  Marco, B.; Astrid, E.; Michele, T.; Achille, U. R. Angew. Chem., Int. Ed. 2008, 47, 3238. doi: 10.1002/(ISSN)1521-3773
31. [31]
  Mathieu, G.; Olivier, B. Org. Lett. 2012, 14, 398. doi: 10.1021/ol2031763
32. [32]
  Bian, C. C.; Yan, R.; Yu, X. M. Tetrahedron 2014, 70, 2982. doi: 10.1016/j.tet.2014.03.020
33. [33]
  Bosanac, T.; Hickey, E. R.; Ginn, J.; Kashem, M.; Kerr, S., Kugler, S.; Li, X.; Olague, A.; Schlyer, S.; Young, E. R. Bioorg. Med. Chem. Lett. 2010, 20, 3746. doi: 10.1016/j.bmcl.2010.04.069
1. [1]
  Yihui Song , Shangshang Qin , Kai Wu , Chengyun Jin , Bin Yu . 生物化学在高水平创新型药学人才培养中的交叉融合应用——以去甲基化酶LSD1抑制剂的活性评价为例. University Chemistry, 2025, 40(6): 341-352. doi: 10.12461/PKU.DXHX202406018
2. [2]
  Jianfeng Yan , Yating Xiao , Xin Zuo , Caixia Lin , Yaofeng Yuan . Comprehensive Chemistry Experimental Design of Ferrocenylphenyl Derivatives. University Chemistry, 2024, 39(4): 329-337. doi: 10.3866/PKU.DXHX202310005
3. [3]
  Siran Wang , Yinuo Wang , Yilong Zhao , Dazhen Xu . Advances in the Application and Preparation of Rhodanine and Its Derivatives. University Chemistry, 2025, 40(5): 318-327. doi: 10.12461/PKU.DXHX202407033
4. [4]
  Bo YANG , Gongxuan LÜ , Jiantai MA . Corrosion inhibition of nickel-cobalt-phosphide in water by coating TiO₂ layer. Chinese Journal of Inorganic Chemistry, 2025, 41(2): 365-384. doi: 10.11862/CJIC.20240063
5. [5]
  Jia-He Li , Yu-Ze Liu , Jia-Hui Ma , Qing-Xiao Tong , Jian-Ji Zhong , Jing-Xin Jian . 洛芬碱衍生物的合成、化学发光与重金属离子检测. University Chemistry, 2025, 40(6): 230-237. doi: 10.12461/PKU.DXHX202407080
6. [6]
  Zhongyan Cao , Shengnan Jin , Yuxia Wang , Yiyi Chen , Xianqiang Kong , Yuanqing Xu . Advances in Highly Selective Reactions Involving Phenol Derivatives as Aryl Radical Precursors. University Chemistry, 2025, 40(4): 245-252. doi: 10.12461/PKU.DXHX202405186
7. [7]
  Yonghui ZHOU , Rujun HUANG , Dongchao YAO , Aiwei ZHANG , Yuhang SUN , Zhujun CHEN , Baisong ZHU , Youxuan ZHENG . Synthesis and photoelectric properties of fluorescence materials with electron donor-acceptor structures based on quinoxaline and pyridinopyrazine, carbazole, and diphenylamine derivatives. Chinese Journal of Inorganic Chemistry, 2024, 40(4): 701-712. doi: 10.11862/CJIC.20230373
8. [8]
  Yikai Wang , Xiaolin Jiang , Haoming Song , Nan Wei , Yifan Wang , Xinjun Xu , Cuihong Li , Hao Lu , Yahui Liu , Zhishan Bo . 氰基修饰的苝二酰亚胺衍生物作为膜厚不敏感型阴极界面材料用于高效有机太阳能电池. Acta Physico-Chimica Sinica, 2025, 41(3): 2406007-. doi: 10.3866/PKU.WHXB202406007
9. [9]
  Lei Shu , Zhengqing Hao , Kai Yan , Hong Wang , Lihua Zhu , Fang Chen , Nan Wang . Development of a Double-Carbon Related Experiment: Preparation, Characterization and Carbon-Capture Ability of Eggshell-Derived CaO. University Chemistry, 2024, 39(4): 149-156. doi: 10.3866/PKU.DXHX202310134
10. [10]
  Siyu Zong , Xiaowei Yu , Yining Yang , Xin Yang , Jiyang Li . Multi-mode luminescence anti-counterfeiting and visual iron(Ⅲ) ions RTP detection constructed by assembly of CDs&Eu³⁺ in porous RHO zeolite. Chinese Chemical Letters, 2025, 36(6): 110343-. doi: 10.1016/j.cclet.2024.110343
11. [11]
  Wenwei Zhang , Yanping Ren , Weihong Li , Xiaohang Qiu , Mei Shi , Yuwen Liu , Zhilin Wang . Suggestions on Teaching Contents and Requirements of Inorganic Chemistry Experiment for Chemistry Majors in Higher Education. University Chemistry, 2025, 40(5): 23-31. doi: 10.12461/PKU.DXHX202405120
12. [12]
  Xiaotian ZHU , Fangding HUANG , Wenchang ZHU , Jianqing ZHAO . Layered oxide cathode for sodium-ion batteries: Surface and interface modification and suppressed gas generation effect. Chinese Journal of Inorganic Chemistry, 2025, 41(2): 254-266. doi: 10.11862/CJIC.20240260
13. [13]
  Lina Liu , Xiaolan Wei , Jianqiang Hu . Exploration of Subject-Oriented Undergraduate Comprehensive Chemistry Experimental Teaching Based on the “STS Concept”: Taking the Experiment of Gold Nanoparticles as an Example. University Chemistry, 2024, 39(10): 337-343. doi: 10.12461/PKU.DXHX202405112
14. [14]
  Xinyu ZENG , Guhua TANG , Jianming OUYANG . Inhibitory effect of Desmodium styracifolium polysaccharides with different content of carboxyl groups on the growth, aggregation and cell adhesion of calcium oxalate crystals. Chinese Journal of Inorganic Chemistry, 2024, 40(8): 1563-1576. doi: 10.11862/CJIC.20230374
15. [15]
  Linjie ZHU , Xufeng LIU . Electrocatalytic hydrogen evolution performance of tetra-iron complexes with bridging diphosphine ligands. Chinese Journal of Inorganic Chemistry, 2025, 41(2): 321-328. doi: 10.11862/CJIC.20240207
16. [16]
  Anqiu LIU , Long LIN , Dezhi ZHANG , Junyu LEI , Kefeng WANG , Wei ZHANG , Junpeng ZHUANG , Haijun HAO . Synthesis, structures, and catalytic activity of aluminum and zinc complexes chelated by 2-((2,6-dimethylphenyl)amino)ethanolate. Chinese Journal of Inorganic Chemistry, 2024, 40(4): 791-798. doi: 10.11862/CJIC.20230424
17. [17]
  Kangmin Wang , Liqiu Wan , Jingyu Wang , Chunlin Zhou , Ke Yang , Liang Zhou , Bijin Li . Multifunctional 2-(2′-hydroxyphenyl)benzoxazoles: Ready synthesis, mechanochromism, fluorescence imaging, and OLEDs. Chinese Chemical Letters, 2024, 35(10): 109554-. doi: 10.1016/j.cclet.2024.109554
18. [18]
  Xiaofeng Xia , Jielian Zhu . Innovative Comprehensive Experimental Design: Synthesis of 6-Fluoro-N-benzoyl Tetrahydroquinoline. University Chemistry, 2024, 39(10): 344-352. doi: 10.12461/PKU.DXHX202405063
19. [19]
  Zian Lin , Yingxue Jin . Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry (MALDI-MS) for Disease Marker Screening and Identification: A Comprehensive Experiment Teaching Reform in Instrumental Analysis. University Chemistry, 2024, 39(11): 327-334. doi: 10.12461/PKU.DXHX202403066
20. [20]
  Yuexiang Liu , Xiangqiao Yang , Tong Lin , Guantian Yang , Xiaoyong Xu , Bubing Zeng , Zhong Li , Weiping Zhu , Xuhong Qian . Efficient continuous synthesis of 2-[3-(trifluoromethyl)phenyl]malonic acid, a key intermediate of Triflumezopyrim, coupling with esterification-condensation-hydrolysis. Chinese Chemical Letters, 2025, 36(1): 109747-. doi: 10.1016/j.cclet.2024.109747

Get Citation

PDF

XML

Metrics

PDF Downloads(12)
Abstract views(1541)
HTML views(758)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142